Literature DB >> 13234351

Aplastic anaemia following mepacrine treatment of lupus erythematosus.

M D PATON, M J RIDDELL, J A STRONG.   

Abstract

Entities:  

Keywords:  ANEMIA, APLASTIC/etiology and pathogenesis; LUPUS ERYTHEMATOSUS/therapy; QUINACRINE/injurious effects

Mesh：

Substances：

Year:  1955        PMID： 13234351     DOI： 10.1016/s0140-6736(55)90109-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Chloroquine and rheumatoid arthritis; a short-term controlled trial.

Authors:  A FREEDMAN
Journal:  Ann Rheum Dis       Date:  1956-09       Impact factor: 19.103

2.  Marrow transplantation for severe aplastic anemia associated with exposure to quinacrine.

Authors:  I Schmid; C Anasetti; F B Petersen; R Storb
Journal:  Blut       Date:  1990 Aug-Sep

3.  Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study.

Authors:  Lavanya Mittal; Lingqiao Zhang; Rui Feng; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2017-10-06       Impact factor: 11.527

4.  Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers.

Authors:  Reza Ehsanian; Carter Van Waes; Stephan M Feller
Journal:  Cell Commun Signal       Date:  2011-05-15       Impact factor: 5.712
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.